Recent Investments

A Fund Overview Since its founding in 2007, the KFBS PE Fund has made investments in 26 portfolio companies, exited 5 portfolio companies, and received 5 dividend recapitalizations. The Fund currently manages $4.4 million in assets, and holds 21 active investments, of which some are highlighted below:

Clearside Biomedical Clearside Biomedical is an ophthalmic company specializing in the research, development and commercialization of therapeutic products through a proprietary ocular microinjection platform that targets the individual compartments of the eye. Currently, Clearside Biomedical is focused on its initial product candidate, CLS1001, under development for retinal applications through the delivery of proven therapeutics to the suprachoroidal space. Clearside Biomedical was founded by an executive team with extensive development and revenue growth expertise, focused on improving the delivery of therapeutic agents to improve standard of care for patients with sight threatening disease.

News

Clearside Biomedical Closes $4mm Venture Financing

Ophthalmic startup Clearside Biomedical and Hatteras Venture Partners announced they have launched the company with a $4,000,000... Read more »

Z Capital and James Zenni provide $100K grant to UNC Kenan-Flagler

Z Capital Partners and James J. Zenni have provided a $100,000 grant to the University of North Carolina’s Kenan-Flagler... Read more »